Both in Pharmaceuticals
Harrow vs Maravai LifeSciences Holdings
Over the past year HROW returned −26.5% and MRVI returned +143.2%; their daily moves had a correlation of 0.26.
HROW −26.5% MRVI +143.2%Growth of $1, one year, split-adjusted
| Metric | HROW | MRVI |
|---|---|---|
| Price | $26.04 | $6.98 |
| Market cap | $976.2M | $1.04B |
| Today | −9.43% | −9.59% |
| 1 month | −15.0% | −6.1% |
| 6 months | −33.3% | +77.2% |
| Year to date | −46.9% | +114.8% |
| 1 year | −26.3% | +143.2% |
| Revenue growth (YoY) | +10.9% | +8.5% |
| Gross margin | 71.3% | 40.1% |
| Net margin | −24.4% | −24.1% |
| P/E (TTM) | — | — |
| Price / sales | 3.5× | 5.0× |
| Net cash | -$208.5M | -$106.6M |
| Dividend yield | — | — |
| Volatility (60d) | 44.2% | 88.9% |
| Short % of float | 24.3% | 10.7% |
| Next earnings | — | — |
Shading marks the stronger figure where one clearly exists (lower is better for valuation and volatility).